Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06830980 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
A NA study of HIV and Methamphetamine Use Disorders, sponsored by Gopalkumar Rakesh.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06830980: Recruiting NA study of HIV and Methamphetamine Use Disorders, sponsored by Gopalkumar Rakesh.
NCT06830980 is a NA study of HIV and Methamphetamine Use Disorders that is actively recruiting participants, run by Gopalkumar Rakesh. The registered enrollment target is 30 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06830980, a NA study of HIV and Methamphetamine Use Disorders, is actively recruiting participants, sponsored by Gopalkumar Rakesh.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about how accelerated theta burst stimulation affects methamphetamine craving and brain activity. Theta burst stimulation is a unique transcranial magnetic stimulation (TMS) paradigm that is efficient and potent.
Primary Outcome
Measured on the visual analog scale (VAS) Scored 0 to 100 with 0=no craving and 100=the most craving.
Conditions Studied
Interventions
- DEVICE continuous theta burst stimulation (cTBS)
- DEVICE intermittent theta burst stimulation (iTBS)
- DEVICE Sham TMS
Study Locations (1)
Kentucky
- UK Department of Psychiatry - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06830980 shows while recruiting
NCT06830980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 3 interventions - of which continuous theta burst stimulation (cTBS) is the first listed.
NCT06830980 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06830980 about?
NCT06830980 is a clinical study titled "Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH". The purpose of this study is to learn more about how accelerated theta burst stimulation affects methamphetamine craving and brain activity. Theta burst stimulation is a unique transcranial magnetic stimulation (TMS) paradigm that is efficient and potent.
What is the current status of trial NCT06830980?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-11. Estimated completion is 2026-12-31.
What conditions does trial NCT06830980 study?
This clinical trial studies the following conditions: HIV, Methamphetamine Use Disorders.
What interventions are being tested in trial NCT06830980?
The interventions under investigation include: continuous theta burst stimulation (cTBS) (DEVICE), intermittent theta burst stimulation (iTBS) (DEVICE), Sham TMS (DEVICE).
Who is sponsoring clinical trial NCT06830980?
This trial is sponsored by Gopalkumar Rakesh, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06830980 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06830980's enrollment target sits among peer trials
30 264th of 303 higher than 31 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI